Comparative efficacy, safety, and tolerability of pharmacotherapies for acute mania in adults: a systematic review and network meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Comparative efficacy, safety, and tolerability of pharmacotherapies for acute mania in adults: a systematic review and network meta-analysis of randomized controlled trials

Published:2024-08-27 Issue: Volume: Page:
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Huang Wenbo^ORCID,He Shuyang,Liu Mingxin^ORCID,Xu Jilai

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41380-024-02705-3.pdf

Reference46 articles.

1. Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016;387:1561–72.

2. McIntyre RS, Berk M, Brietzke E, Goldstein BI, López-Jaramillo C, Kessing LV, et al. Bipolar disorders. Lancet. 2020;396:1841–56.

3. National Collaborating Centre for Mental H. National Institute for Health and Clinical Excellence: Guidance. Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care. British Psychological Society Copyright © 2006, The British Psychological Society & The Royal College of Psychiatrists: Leicester (UK), 2006.

4. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20:97–170.

5. Fountoulakis KN, Yatham L, Grunze H, Vieta E, Young A, Blier P, et al. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), part 2: review, grading of the evidence, and a precise algorithm. Int J Neuropsychopharmacol. 2017;20:121–79.